BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6264937)

  • 1. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration.
    Feely J; Crooks J; Stevenson IH
    Br J Clin Pharmacol; 1981 Jul; 12(1):73-8. PubMed ID: 6264937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma propranolol steady state concentrations in thyroid disorders.
    Feely J; Crooks J; Stevenson IH
    Eur J Clin Pharmacol; 1981; 19(5):329-33. PubMed ID: 7238561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism.
    Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1978 Aug; 6(2):123-7. PubMed ID: 678388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma protein binding of drugs in thyroid disease.
    Feely J; Stevenson IH; Crooks J
    Clin Pharmacokinet; 1981; 6(4):298-305. PubMed ID: 7249488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of surgery on plasma propranolol levels and protein binding.
    Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J
    Clin Pharmacol Ther; 1980 Dec; 28(6):759-64. PubMed ID: 7438691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased clearance of propranolol in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
    Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
    Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
    Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol dosage in thyrotoxicosis.
    Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J
    J Clin Endocrinol Metab; 1980 Sep; 51(3):658-61. PubMed ID: 7410541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of propranolol on the plasma cyclic AMP and cyclic GMP levels to massive doses of glucagon in euthyroid and hyperthyroid subjects.
    Földes J; Gyertyánfy G; Piroska E; Juhász J
    Acta Med Acad Sci Hung; 1977; 34(4):227-34. PubMed ID: 218419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age and hyperthyroidism on plasma propranolol steady state concentration [proceedings].
    Feely J; Stevenson IH
    Br J Clin Pharmacol; 1978 Nov; 6(5):446P. PubMed ID: 728296
    [No Abstract]   [Full Text] [Related]  

  • 12. Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans.
    Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
    Clin Pharmacol Ther; 1992 May; 51(5):549-54. PubMed ID: 1316824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No enhanced elimination of propranolol in patients with hyperthyroidism.
    Ishizaki T; Masuno M; Tawara K
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ketonaemia in hyperthyroidism: study of the role of free fatty acids.
    Beylot M; Cohen R; Riou JP; Sautot G; Garcia I; Noel G; Mornex R
    Diabete Metab; 1983 Sep; 9(3):217-23. PubMed ID: 6360743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism].
    Beylot M; Riou JP; Sautot G; Mornex R
    Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol dynamics in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1980 Jul; 28(1):40-4. PubMed ID: 7389252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine increases steady state plasma levels of propranolol.
    Reimann IW; Klotz U; Siems B; Frölich J
    Br J Clin Pharmacol; 1981 Dec; 12(6):785-90. PubMed ID: 7340880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compared effect of propranolol and acebutolol on serum thyroid hormones' levels in euthyroid and hyperthyroid patients: a randomized study.
    Perret G; Hugues JN; Modigliani E; Sebaoun J
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):360-4. PubMed ID: 6469425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of propranolol used for suppressing tachycardia in hyperthyroidism.
    Musha H; Murayama M; Motohashi F; Masuda H; Takada H; Miyake F; Sugai J
    Jpn Heart J; 1994 Jan; 35(1):51-60. PubMed ID: 8201781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.